pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    promethazine
    Promethazine Hydrochloride (promethazine [INN])
    Allergic Conjunctivitis Nostrum Laboratories LLC
  • Marketed
    ranibizumab
    Lucentis (ranibizumab)
    Choroidal Neovascularization Genentech Inc
  • Marketed
    revakinagene taroretcel
    Encelto (revakinagene taroretcel-iwey)
    Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT) Neurotech Pharmaceuticals Inc
  • Phase 3
← prev
page 12 of 13
next →
Pain89
Neurology1
ripasudil hydrochloride
ripasudil hydrochloride
Fuchs Endothelial Corneal Dystrophy (FECD)
Kowa Co Ltd
  • Phase 2
    risuteganib
    Luminate (risuteganib)
    Dry (Atrophic) Macular Degeneration Allegro Ophthalmics LLC
  • Phase 2
    rivasterat
    rivasterat [INN]
    Diabetic Macular Edema Thea Open Innovation SASU
  • Phase 3
    satralizumab
    Enspryng (satralizumab-mwge)
    Demyelinating Diseases F. Hoffmann-La Roche Ltd
  • Phase 3
    selenium sulfide
    Selenium Sulfide (selenium sulfide [USP])
    Meibomian Blepharitis Azura Ophthalmics Pty Ltd
  • Phase 2
    sepetaprost
    sepetaprost [INN]
    Ocular Hypertension Santen Pharmaceutical Co Ltd
  • Marketed
    short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT
    Ragwitek
    Ragweed Pollen Allergy ALK-Abello Inc
  • Phase 3
    sonpiretigene isteparvovec
    sonpiretigene isteparvovec
    Retinitis Pigmentosa (Retinitis) Nanoscope Therapeutics Inc
  • Phase 2
    sozinibercept
    sozinibercept
    Diabetic Macular Edema$CKDXF Opthea Ltd
  • Marketed
    standardized grass pollen [timothy (Phleum pratense)] allergen extract
    Grastek
    Allergic Rhinitis ALK-Abello Inc
  • Marketed
    standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract
    Odactra
    Allergic Rhino-Conjunctivitis ALK-Abello Inc
  • Marketed
    sulfadiazine
    Sulfadiazine
    Otitis Media Epic Pharma LLC
  • Marketed
    sulfisoxazole
    Sulfisoxazole
    Bacterial (Pyogenic) Meningitis Roxane Laboratories Inc
  • Phase 3
    surabgene lomparvovec
    surabgene lomparvovec
    Wet (Neovascular / Exudative) Macular Degeneration$ABBV AbbVie Inc.
  • Phase 3
    tarcocimab tedromer
    tarcocimab tedromer
    Retinal Vein Occlusion$KOD Kodiak Sciences Inc.
  • Phase 1
    tasronetide
    tasronetide [INN]
    Optic Neuropathy Find Therapeutics Inc
  • Phase 3
    tavilermide
    tavilermide
    Keratoconjunctivitis Sicca (Dry Eye) Mimetogen Pharmaceuticals Inc
  • Marketed
    tetracycline hydrochloride
    Tetracycline Hydrochloride
    Actinomycosis Amneal Pharmaceuticals of New York LLC
  • Phase 3
    timbetasin acetate
    timbetasin acetate
    Neurotrophic Keratitis ReGenTree LLC
  • Phase 2
    timolol
    timolol
    Ocular Hypertension Betaliq Inc
  • Phase 3
    tinlarebant
    tinlarebant
    Geographic Atrophy$BLTE BELITE BIO, INC
  • Phase 2
    tivozanib
    tivozanib
    Wet (Neovascular / Exudative) Macular Degeneration Kyowa Kirin Co Ltd
  • Marketed
    tobramycin
    Tobramycin Sulfate (tobramycin)
    Bacteremia Hikma Pharmaceuticals USA Inc
  • Phase 2
    tonabersat
    Xiflam (tonabersat [INN])
    Diabetic Nephropathy Inflammx Therapeutics Inc
  • Preclinical
    triamcinolone acetonide SR
    triamcinolone acetonide [INN]
    Diabetic Macular Edema$GKOS GLAUKOS Corp
  • Marketed
    trifluridine
    Trifluridine
    Herpetic Keratitis Sandoz Inc
  • Marketed
    tropicamide
    Mydriacyl (tropicamide)
    Cycloplegia Alcon Laboratories Inc